Thursday, May 3, 2018

Liraglutide May Affect Clinical Outcomes of Myocardial Infarction in Type 2 Diabetes

Liraglutide may reduce the incidence of myocardial infarction in patients who have a high cardiovascular risk with type 2 diabetes.
Liraglutide May Affect Clinical Outcomes of Myocardial Infarction in Type 2 Diabetes posted first on https://www.youtube.com/dailyhealthpost/

No comments:

Post a Comment